Journal article
1641P Phase I/II trial of oral masofaniten (EPI-7386) in combination with enzalutamide (Enz) compared to enz alone in metastatic castration-resistant prostate cancer (mCRPC) subjects
Authors
Kyriakopoulos C; Chatta G; Laccetti AL; Iannotti N; Sokolova AO; Hotte SJ; Tutrone R; Markowski MC; Nordquist LT; Pili R
Journal
Annals of Oncology, Vol. 35, ,
Publisher
Elsevier
Publication Date
September 1, 2024
DOI
10.1016/j.annonc.2024.08.1722
ISSN
0923-7534